Hiroko Kanda
Impact in
- Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Immunology top 10%
- T-cell and B-cell Immunology
- Complement system in diseases
Papers in
- Rheumatology 30
- Rheumatoid Arthritis Research and Therapies 15
- Systemic Lupus Erythematosus Research 12
- Spondyloarthritis Studies and Treatments 3
- Immunology 13
- T-cell and B-cell Immunology 6
- Psoriasis: Treatment and Pathogenesis 4
- Immunodeficiency and Autoimmune Disorders 2
- Co-authors
- Kazuhiko Yamamoto (27 shared papers)Toshihide Mimura (10 shared papers)Kanae Kubo (16 shared papers)Keishi Fujio (19 shared papers)Shoko Tateishi (18 shared papers)Ken Hamasaki (6 shared papers)Yasuo Nagafuchi (9 shared papers)Shuji Sumitomo (7 shared papers)
In The Last Decade
Hiroko Kanda
54 papers receiving 859 citations
Peers
Comparison fields: 5 of 68
- Rheumatology 328
- Immunology 197
- Ophthalmology 59
- Nephrology 53
- Immunology and Allergy 22
Countries citing papers authored by Hiroko Kanda
This map shows the geographic impact of Hiroko Kanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Kanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Kanda more than expected).
Fields of papers citing papers by Hiroko Kanda
This network shows the impact of papers produced by Hiroko Kanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Kanda. The network helps show where Hiroko Kanda may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroko Kanda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 78 | |
| 2 | 2003 | 59 | |
| 3 | 2017 | 58 | |
| 4 | 2007 | 53 | |
| 5 | 2016 | 53 | |
| 6 | 2005 | 42 | |
| 7 | 2023 | 37 | |
| 8 | Antiinflammatory effect of simvastatin in patients with rheumatoid arthritis. | 2002 | 35 |
| 9 | 2012 | 31 | |
| 10 | 2013 | 30 | |
| 11 | 1997 | 29 | |
| 12 | 2019 | 28 | |
| 13 | 2018 | 26 | |
| 14 | 2017 | 22 | |
| 15 | 1999 | 20 | |
| 16 | 2022 | 20 | |
| 17 | 2006 | 19 | |
| 18 | 2004 | 18 | |
| 19 | 2005 | 17 | |
| 20 | 2023 | 16 |
About Hiroko Kanda
Hiroko Kanda is a scholar working on Rheumatology, Immunology, Nephrology, Pulmonary and Respiratory Medicine and Ophthalmology, having authored 57 papers that have together received 889 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (15 papers), Systemic Lupus Erythematosus Research (12 papers), T-cell and B-cell Immunology (6 papers), Vasculitis and related conditions (5 papers), Psoriasis: Treatment and Pathogenesis (4 papers), Inflammatory Myopathies and Dermatomyositis (3 papers), Spondyloarthritis Studies and Treatments (3 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). The work is most often cited by research in Rheumatology (328 citations), Immunology (197 citations), Ophthalmology (59 citations), Nephrology (53 citations) and Immunology and Allergy (22 citations). Hiroko Kanda has collaborated with scholars based in Japan and China. Frequent co-authors include Kazuhiko Yamamoto, Toshihide Mimura, Kanae Kubo, Keishi Fujio, Shoko Tateishi, Ken Hamasaki, Yasuo Nagafuchi, Shuji Sumitomo, Yoshikata Misaki and Haruka Tsuchiya. Their work appears in journals such as Modern Rheumatology, Lupus, Clinical Rheumatology, Scientific Reports and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.